| [1] |
SHEN MY, SHEN Y, FAN XL, et al. Roles of macrophages and exosomes in liver diseases[J]. Front Med(Lausanne), 2020, 7: 583691. DOI: 10.3389/fmed.2020.583691. |
| [2] |
LIU B, WANG JC, WANG GC, et al. Hepatocyte-derived exosomes deliver H2AFJ to hepatic stellate cells and promote liver fibrosis via the MAPK/STMN1 axis activation[J]. Int Immunopharmacol, 2023, 115: 109605. DOI: 10.1016/j.intimp.2022.109605. |
| [3] |
DASGUPTA D, NAKAO Y, MAUER AS, et al. IRE1A stimulates hepatocyte-derived extracellular vesicles that promote inflammation in mice with steatohepatitis[J]. Gastroenterology, 2020, 159( 4): 1487- 1503. e 17. DOI: 10.1053/j.gastro.2020.06.031. |
| [4] |
SHABANGU CS, HUANG JF, HSIAO HH, et al. Liquid biopsy for the diagnosis of viral hepatitis, fatty liver steatosis, and alcoholic liver diseases[J]. Int J Mol Sci, 2020, 21( 10): 3732. DOI: 10.3390/ijms21103732. |
| [5] |
LIU XL, PAN Q, CAO HX, et al. Lipotoxic hepatocyte-derived exosomal microRNA 192-5p activates macrophages through rictor/akt/forkhead box transcription factor O1 signaling in nonalcoholic fatty liver disease[J]. Hepatology, 2020, 72( 2): 454- 469. DOI: 10.1002/hep.31050. |
| [6] |
PAN Y, TAN WF, YANG MQ, et al. The therapeutic potential of exosomes derived from different cell sources in liver diseases[J]. Am J Physiol Gastrointest Liver Physiol, 2022, 322( 4): G397- G404. DOI: 10.1152/ajpgi.00054.2021. |
| [7] |
JIAO Y, LU W, XU P, et al. Hepatocyte-derived exosome may be as a biomarker of liver regeneration and prognostic valuation in patients with acute-on-chronic liver failure[J]. Hepatol Int, 2021, 15( 4): 957- 969. DOI: 10.1007/s12072-021-10217-3. |
| [8] |
MASTORIDIS S, PATEL V, CHRISTAKOUDI S, et al. Impact of liver failure on the circulating extracellular vesicle miRNA repertoire[J]. Hepatol Res, 2023, 53( 8): 771- 785. DOI: 10.1111/hepr.13909. |
| [9] |
DING Y, LUO QL, QUE HY, et al. Mesenchymal stem cell-derived exosomes: A promising therapeutic agent for the treatment of liver diseases[J]. Int J Mol Sci, 2022, 23( 18): 10972. DOI: 10.3390/ijms231810972. |
| [10] |
LU XF, GUO HJ, WEI XY, et al. Current status and prospect of delivery vehicle based on mesenchymal stem cell-derived exosomes in liver diseases[J]. Int J Nanomedicine, 2023, 18: 2873- 2890. DOI: 10.2147/IJN.S404925. |
| [11] |
ELSHARKASY OM, NORDIN JZ, HAGEY DW, et al. Extracellular vesicles as drug delivery systems: Why and how?[J]. Adv Drug Deliv Rev, 2020, 159: 332- 343. DOI: 10.1016/j.addr.2020.04.004. |
| [12] |
ZHANG SQ, HOU Y, YANG J, et al. Application of mesenchymal stem cell exosomes and their drug-loading systems in acute liver failure[J]. J Cell Mol Med, 2020, 24( 13): 7082- 7093. DOI: 10.1111/jcmm.15290. |
| [13] |
ZHANG SQ, JIANG LR, HU HZ, et al. Pretreatment of exosomes derived from hUCMSCs with TNF-α ameliorates acute liver failure by inhibiting the activation of NLRP3 in macrophage[J]. Life Sci, 2020, 246: 117401. DOI: 10.1016/j.lfs.2020.117401. |
| [14] |
DENG CQ, HU J, HE L, et al. Daucosterol combined with umbilical cord mesenchymal stem cell-derived exosomes can alleviate liver damage in liver failure mice by regulating the IL-6/STAT3 signaling pathway[J]. Cancer Biol Ther, 2023, 24( 1): 2184150. DOI: 10.1080/15384047.2023.2184150. |
| [15] |
LIU YN, LOU GH, LI AC, et al. AMSC-derived exosomes alleviate lipopolysaccharide/d-galactosamine-induced acute liver failure by miR-17-mediated reduction of TXNIP/NLRP3 inflammasome activation in macrophages[J]. EBioMedicine, 2018, 36: 140- 150. DOI: 10.1016/j.ebiom.2018.08.054. |
| [16] |
CHEN L, CHEN RJ, KEMPER S, et al. Therapeutic effects of serum extracellular vesicles in liver fibrosis[J]. J Extracell Vesicles, 2018, 7( 1): 1461505. DOI: 10.1080/20013078.2018.1461505. |
| [17] |
WU HY, ZHANG XC, JIA BB, et al. Exosomes derived from human umbilical cord mesenchymal stem cells alleviate acetaminophen-induced acute liver failure through activating ERK and IGF-1R/PI3K/AKT signaling pathway[J]. J Pharmacol Sci, 2021, 147( 1): 143- 155. DOI: 10.1016/j.jphs.2021.06.008. |
| [18] |
YAN YM, JIANG WQ, TAN YW, et al. hucMSC exosome-derived GPX1 is required for the recovery of hepatic oxidant injury[J]. Mol Ther, 2017, 25( 2): 465- 479. DOI: 10.1016/j.ymthe.2016.11.019. |
| [19] |
ZHAO SX, LIU Y, PU ZH. Bone marrow mesenchymal stem cell-derived exosomes attenuate D-GaIN/LPS-induced hepatocyte apoptosis by activating autophagy in vitro[J]. Drug Des Devel Ther, 2019, 13: 2887- 2897. DOI: 10.2147/DDDT.S220190. |
| [20] |
LIN DN, CHEN H, XIONG J, et al. Mesenchymal stem cells exosomal let-7a-5p improve autophagic flux and alleviate liver injury in acute-on-chronic liver failure by promoting nuclear expression of TFEB[J]. Cell Death Dis, 2022, 13( 10): 865. DOI: 10.1038/s41419-022-05303-9. |
| [21] |
YANG B, DUAN W, WEI L, et al. Bone marrow mesenchymal stem cell-derived hepatocyte-like cell exosomes reduce hepatic ischemia/reperfusion injury by enhancing autophagy[J]. Stem Cells Dev, 2020, 29( 6): 372- 379. DOI: 10.1089/scd.2019.0194. |
| [22] |
ZHANG L, SONG YL, CHEN L, et al. MiR-20a-containing exosomes from umbilical cord mesenchymal stem cells alleviates liver ischemia/reperfusion injury[J]. J Cell Physiol, 2020, 235( 4): 3698- 3710. DOI: 10.1002/jcp.29264. |
| [23] |
XUE TM, YAM JWP. Role of small extracellular vesicles in liver diseases: Pathogenesis, diagnosis, and treatment[J]. J Clin Transl Hepatol, 2022, 10( 6): 1176- 1185. DOI: 10.14218/JCTH.2022.00008. |
| [24] |
BALA S, TILAHU Y, TAHAA O, et al. Increased microRNA-155 expression in the serum and peripheral monocytes in chronic HCV infection[J]. Transl Med, 2012, 10: 151. DOI: 10.1186/1479-5876-10-151. |
| [25] |
XU WL, YU MX, WU YK, et al. Plasma-derived exosomal SncRNA as a promising diagnostic biomarker for early detection of HBV-related acute-on-chronic liver failure[J]. Front Cell Infect Microbiol, 2022, 12: 923300. DOI: 10.3389/fcimb.2022.923300. |
| [26] |
CHEN JJ, XU QS, ZHANG Y, et al. RNA profiling analysis of the serum exosomes derived from patients with chronic hepatitis and acute-on-chronic liver failure caused by HBV[J]. Sci Rep, 2020, 10( 1): 1528. DOI: 10.1038/s41598-020-58233-x. |
| [27] |
GAO S, FAN YC, HAN LY, et al. Serum exosomal long noncoding RNA nuclear-enriched abundant transcript 1 predicts 90-day mortality in acute-on-chronic hepatitis B liver failure[J]. Expert Rev Clin Immunol, 2021, 17( 7): 789- 797. DOI: 10.1080/1744666X.2021.1933442. |
| [28] |
SUN CX, HAN LY, WANG K, et al. Serum exosomal long noncoding RNA growth arrest-specific 5 predicts 3-month mortality in acute-on-chronic hepatitis B liver failure[J]. J Inflamm Res, 2023, 16: 4603- 4616. DOI: 10.2147/JIR.S423321. |
| [29] |
XIANG Z, JIANG B, LI W, et al. The diagnostic and prognostic value of serum exosome-derived carbamoyl phosphate synthase 1 in HEV-related acute liver failure patients[J]. J Med Virol, 2022, 94( 10): 5015- 5025. DOI: 10.1002/jmv.27961. |
| [30] |
HARRELL CR, PAVLOVIC D, DJONOV V, et al. Therapeutic potential of mesenchymal stem cells in the treatment of acute liver failure[J]. World J Gastroenterol, 2022, 28( 28): 3627- 3636. DOI: 10.3748/wjg.v28.i28.3627. |
| [31] |
SHOKRAVI S, BORISOV V, ZAMAN BA, et al. Mesenchymal stromal cells(MSCs) and their exosome in acute liver failure(ALF): A comprehensive review[J]. Stem Cell Res Ther, 2022, 13( 1): 192. DOI: 10.1186/s13287-022-02825-z. |
| [32] |
SHAO MY, XU Q, WU ZR, et al. Exosomes derived from human umbilical cord mesenchymal stem cells ameliorate IL-6-induced acute liver injury through miR-455-3p[J]. Stem Cell Res Ther, 2020, 11( 1): 37. DOI: 10.1186/s13287-020-1550-0. |
| [33] |
CHEN L, XIANG BY, WANG XJ, et al. Exosomes derived from human menstrual blood-derived stem cells alleviate fulminant hepatic failure[J]. Stem Cell Res Ther, 2017, 8( 1): 9. DOI: 10.1186/s13287-016-0453-6. |
| [34] |
ZHANG J, GAO J, LIN DN, et al. Potential networks regulated by MSCs in acute-on-chronic liver failure: Exosomal miRNAs and intracellular target genes[J]. Front Genet, 2021, 12: 650536. DOI: 10.3389/fgene.2021.650536. |
| [35] |
ZHENG L, LI Z, LING W, et al. Exosomes derived from dendritic cells attenuate liver injury by modulating the balance of Treg and Th17 cells after ischemia reperfusion[J]. Cell Physiol Biochem, 2018, 46( 2): 740- 756. DOI: 10.1159/000488733. |
| [36] |
CALLERI A, ROGGIO D, NAVARRO-TABLEROS V, et al. Protective effects of human liver stem cell-derived extracellular vesicles in a mouse model of hepatic ischemia-reperfusion injury[J]. Stem Cell Rev Rep, 2021, 17( 2): 459- 470. DOI: 10.1007/s12015-020-10078-7. |
| [37] |
NOJIMA H, FREEMAN CM, SCHUSTER RM, et al. Hepatocyte exosomes mediate liver repair and regeneration via sphingosine-1-phosphate[J]. J Hepatol, 2016, 64( 1): 60- 68. DOI: 10.1016/j.jhep.2015.07.030. |
| [38] |
LU W, TANG HX, LI SS, et al. Extracellular vesicles as potential biomarkers and treatment options for liver failure: A systematic review up to March 2022[J]. Front Immunol, 2023, 14: 1116518. DOI: 10.3389/fimmu.2023.1116518. |
| [39] |
CHEN Q, JIN MX, WANG SM, et al. Establishing an hTERT-driven immortalized umbilical cord-derived mesenchymal stem cell line and its therapeutic application in mice with liver failure[J]. J Tissue Eng, 2023, 14: 20417314231200328. DOI: 10.1177/20417314231200328. |
DownLoad: